InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Dicicco Wendy F, Director. Director active across 4 companies, notably Renovacor, Inc.. Cumulatively, 10 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €18k. History available since 24 January 2022. The latest transaction was filed on 20 August 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
DICICCO WENDY F is Interim Chief Financial Officer and Director. She is linked to SWK Holdings Corp, EyePoint Pharmaceuticals, Inc., Renovacor, Inc. and Akari Therapeutics Plc. The record shows 10 filings in total, and within the sampled recent filings the period runs from 2022-01-26 to 2024-08-21, with buys of EUR 17970 and no sells; the modal transaction nature is Attribution.